id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-307813-elom30nx	Yip, Tsz-Fung	Advancements in Host-Based Interventions for Influenza Treatment	2018-07-10		.txt	text/plain	15110	474	27	Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency Disease-promoting effects of type I interferons in viral, bacterial, and coinfections Protection from lethal influenza virus challenge by oral type 1 interferon Low-dose oral interferon alpha as prophylaxis against viral respiratory illness: a double-blind, parallel controlled trial during an influenza pandemic year IFNlambda is a potent anti-influenza therapeutic without the inflammatory side effects of IFNalpha treatment Pathogenic potential of interferon alphabeta in acute influenza infection The superiority of IFN-lambda as a therapeutic candidate to control acute influenza viral lung infection Type I interferon induction during influenza virus infection increases susceptibility to secondary Streptococcus pneumoniae infection by negative regulation of gammadelta T cells Interferon-lambda mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness RIG-I activation protects and rescues from lethal influenza virus infection and bacterial superinfection Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro Avian influenza A H7N9 virus induces severe pneumonia in mice without prior adaptation and responds to a combination of zanamivir and COX-2 inhibitor Role of cyclooxygenase-2 in H5N1 viral pathogenesis and the potential use of its inhibitors Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages Modified Jiu Wei Qiang Huo decoction improves dysfunctional metabolomics in influenza A pneumoniainfected mice Pattern recognition receptors and inflammation Cutting edge: There is an urgent need to search for alternative targets to treat influenza virus infections, including non-viral targets such as host cellular factors; which are promising as viruses rely on the host machinery for replication.	cache/cord-307813-elom30nx.txt	txt/cord-307813-elom30nx.txt
